Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMERSION CORP Major Shareholding Notification 2016

Aug 9, 2016

33559_mrq_2016-08-09_3d838261-6ac9-42ca-bd89-bd827f5cf9b9.zip

Major Shareholding Notification

Open in viewer

Opens in your device viewer

SC 13D/A 1 sc13da110114018_08092016.htm sc13da110114018_08092016.htm Licensed to: Olshan Document Created using EDGARizer 2020 5.5.2.0 Copyright 1995 - 2015 Summit Financial Printing. All rights reserved.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

§ 240.13d-2(a)

(Amendment No. 1) 1

Immersion Corporation

(Name of Issuer)

Common Stock, $0.001 par value

(Title of Class of Securities)

452521107

(CUSIP Number)

ERIC SINGER

VIEX CAPITAL ADVISORS, LLC

825 Third Avenue, 33rd Floor

New York, New York 10022

STEVE WOLOSKY, ESQ.

OLSHAN FROME WOLOSKY LLP

1325 Avenue of the Americas

New York, New York 10019

(212) 451-2300

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

August 5, 2016

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box ¨ .

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.


1 The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes ).

CUSIP NO. 452521107

1 NAME OF REPORTING PERSON VIEX Opportunities Fund, LP - Series One*
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) o
3 SEC USE ONLY
4 SOURCE OF FUNDS WC
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) ¨
6 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER - 0 -
8 SHARED VOTING POWER 284,668
9 SOLE DISPOSITIVE POWER - 0 -
10 SHARED DISPOSITIVE POWER 284,668
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 284,668
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES o
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 1.0%
14 TYPE OF REPORTING PERSON PN
  • This Series One is part of a series of VIEX Opportunities Fund, LP, a series limited partnership.

2

CUSIP NO. 452521107

1 NAME OF REPORTING PERSON VIEX Special Opportunities Fund II, LP
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) o
3 SEC USE ONLY
4 SOURCE OF FUNDS WC
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) ¨
6 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER - 0 -
8 SHARED VOTING POWER 1,648,774
9 SOLE DISPOSITIVE POWER - 0 -
10 SHARED DISPOSITIVE POWER 1,648,774
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,648,774
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES o
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.7%
14 TYPE OF REPORTING PERSON PN

3

CUSIP NO. 452521107

1 NAME OF REPORTING PERSON VIEX GP, LLC
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) o
3 SEC USE ONLY
4 SOURCE OF FUNDS AF
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) ¨
6 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER - 0 -
8 SHARED VOTING POWER 284,668
9 SOLE DISPOSITIVE POWER - 0 -
10 SHARED DISPOSITIVE POWER 284,668
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 284,668
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES o
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 1.0%
14 TYPE OF REPORTING PERSON OO

4

CUSIP NO. 452521107

1 NAME OF REPORTING PERSON VIEX Special Opportunities GP II, LLC
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) o
3 SEC USE ONLY
4 SOURCE OF FUNDS AF
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) ¨
6 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER - 0 -
8 SHARED VOTING POWER 1,648,774
9 SOLE DISPOSITIVE POWER - 0 -
10 SHARED DISPOSITIVE POWER 1,648,774
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,648,774
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES o
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.7%
14 TYPE OF REPORTING PERSON OO

5

CUSIP NO. 452521107

1 NAME OF REPORTING PERSON VIEX Capital Advisors, LLC
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) o
3 SEC USE ONLY
4 SOURCE OF FUNDS AF
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) ¨
6 CITIZENSHIP OR PLACE OF ORGANIZATION DELAWARE
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER - 0 -
8 SHARED VOTING POWER 1,933,442
9 SOLE DISPOSITIVE POWER - 0 -
10 SHARED DISPOSITIVE POWER 1,933,442
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,933,442
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES o
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 6.7%
14 TYPE OF REPORTING PERSON IA

6

CUSIP NO. 452521107

1 NAME OF REPORTING PERSON Eric Singer
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) o (b) o
3 SEC USE ONLY
4 SOURCE OF FUNDS AF
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e) ¨
6 CITIZENSHIP OR PLACE OF ORGANIZATION USA
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER - 0 -
8 SHARED VOTING POWER 1,933,442
9 SOLE DISPOSITIVE POWER - 0 -
10 SHARED DISPOSITIVE POWER 1,933,442
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,933,442
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES o
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 6.7%
14 TYPE OF REPORTING PERSON IN

7

CUSIP NO. 452521107

The following constitutes Amendment No. 1 to the Schedule 13D filed by the undersigned (the “Amendment No. 1”). This Amendment No. 1 amends the Schedule 13D as specifically set forth herein.

ITEM 3. Source and Amount of Funds or Other Consideration .

Item 3 is hereby amended and restated to read as follows:

The Shares purchased by Series One were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market purchases, except as otherwise noted, as set forth in Schedule A, which is incorporated by reference herein. The aggregate purchase price of the 284,668 Shares beneficially owned by Series One is approximately $1,906,917, excluding brokerage commissions.

The Shares purchased by VSO II were purchased with working capital (which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business) in open market purchases, except as otherwise noted, as set forth in Schedule A, which is incorporated by reference herein. The aggregate purchase price of the 1,648,774 Shares beneficially owned by VSO II is approximately $12,469,379, excluding brokerage commissions.

ITEM 5. Interest in Securities of the Issuer .

Item 5(a)-(c) is hereby amended and restated to read as follows:

The aggregate percentage of Shares reported owned by each Reporting Person is based upon 28,907,745 Shares outstanding, which is the total number of Shares outstanding as of July 29, 2016 as reported in the Issuer’s Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on August 5, 2016.

A. Series One

(a) As of the close of business on August 8, 2016, Series One beneficially owned 284,668 Shares.

Percentage: Approximately 1.0%

(b) 1. Sole power to vote or direct vote: 0

  1. Shared power to vote or direct vote: 284,668

  2. Sole power to dispose or direct the disposition: 0

  3. Shared power to dispose or direct the disposition: 284,668

(c) The transactions in the Shares by Series One since the filing of the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.

B. VSO II

(a) As of the close of business on August 8, 2016, VSO II beneficially owned 1,648,774 Shares.

Percentage: Approximately 5.7%

8

CUSIP NO. 452521107

(b) 1. Sole power to vote or direct vote: 0

  1. Shared power to vote or direct vote: 1,648,774

  2. Sole power to dispose or direct the disposition: 0

  3. Shared power to dispose or direct the disposition: 1,648,774

(c) The transactions in the Shares by VSO II since the filing of the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.

C. VIEX GP

(a) VIEX GP, as the general partner of Series One, may be deemed the beneficial owner of the 284,668 shares owned by Series One.

Percentage: Approximately 1.0%

(b) 1. Sole power to vote or direct vote: 0

  1. Shared power to vote or direct vote: 284,668

  2. Sole power to dispose or direct the disposition: 0

  3. Shared power to dispose or direct the disposition: 284,668

(c) VIEX GP has not entered into any transactions in the Shares since the filing of the Schedule 13D. The transactions in the shares on behalf of Series One since the filing of the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.

D. VSO GP II

(a) VSO GP II, as the general partner of VSO II, may be deemed the beneficial owner of the 1,648,774 shares owned by VSO II.

Percentage: Approximately 5.7%

(b) 1. Sole power to vote or direct vote: 0

  1. Shared power to vote or direct vote: 1,648,774

  2. Sole power to dispose or direct the disposition: 0

  3. Shared power to dispose or direct the disposition: 1,648,774

(c) VSO GP II has not entered into any transactions in the Shares since the filing of the Schedule 13D. The transactions in the Shares on behalf of VSO II since the filing of the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.

E. VIEX Capital

(a) VIEX Capital, as the investment manager of Series One and VSO II, may be deemed the beneficial owner of the (i) 284,668 Shares owned by Series One and (ii) 1,648,774 owned by VSO II.

Percentage: Approximately 6.7%

(b) 1. Sole power to vote or direct vote: 0

  1. Shared power to vote or direct vote: 1,933,442

  2. Sole power to dispose or direct the disposition: 0

  3. Shared power to dispose or direct the disposition: 1,933,442

9

CUSIP NO. 452521107

(c) VIEX Capital has not entered into any transactions in the Shares since the filing of the Schedule 13D. The transactions in the Shares on behalf of each of Series One and VSO II since the filing of the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.

F. Eric Singer

(a) Mr. Singer, as the managing member of VIEX GP and VIEX Capital, may be deemed the beneficial owner of the (i) 284,668 Shares owned by Series One and (ii) 1,648,774 owned by VSO II.

Percentage: Approximately 6.7%

(b) 1. Sole power to vote or direct vote: 0

  1. Shared power to vote or direct vote: 1,933,442

  2. Sole power to dispose or direct the disposition: 0

  3. Shared power to dispose or direct the disposition: 1,933,442

(c) Mr. Singer has not entered into any transactions in the Shares since the filing of the Schedule 13D. The transactions in the Shares on behalf of each of Series One and VSO II since the filing of the Schedule 13D are set forth in Schedule A and are incorporated herein by reference.

The filing of this Schedule 13D shall not be construed as an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any of the Shares reported herein. Each Reporting Person disclaims beneficial ownership of such Shares except to the extent of his or its pecuniary interest therein.

ITEM 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer .

Item 6 is hereby amended to add the following:

Series One has sold short in over the counter market American-style put options referencing an aggregate of 300,000 Shares and 100 Shares, which have an exercise price of $7.50 and expire on November 18, 2016 and February 17, 2017, respectively.

VSO II has sold short in over the counter market American-style put options referencing an aggregate of 900 Shares, which have an exercise price of $7.50 and expire on February 17, 2017.

10

CUSIP NO. 452521107

SIGNATURES

After reasonable inquiry and to the best of his knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: August 9, 2016

VIEX Opportunities Fund, LP – Series One — By: VIEX GP, LLC General Partner
By: /s/ Eric Singer
Name: Eric Singer
Title: Managing Member
/s/ Eric Singer
Name: Eric Singer
Title: Managing Member
VIEX Special Opportunities Fund II, LP — By: VIEX Special Opportunities GP II, LLC General Partner
By: /s/ Eric Singer
Name: Eric Singer
Title: Managing Member
/s/ Eric Singer
Name: Eric Singer
Title: Managing Member
/s/ Eric Singer
Name: Eric Singer
Title: Managing Member
/s/ Eric Singer
Eric Singer

11

CUSIP NO. 452521107

SCHEDULE A

Transactions in the Shares Since the Filing of the Schedule 13D

Nature of the Transaction Securities Purchased/(Sold) Price Per Share($) Date of Purchase / Sale

VIEX OPPORTUNITIES FUND, LP – SERIES ONE

Purchase of Common Stock 1,036 7.1874 07/08/2016
Short Sale of November 2016 Put Option ($7.50 Strike Price) 3,000 ( 1 ) 0.9500 07/21/2016
Purchase of Common Stock 960 7.5000 07/27/2016
Short Sale of February 2017 Put Option ($7.50 Strike Price) 1 ( 2 ) 1.3500 07/27/2016
Purchase of Common Stock 4,230 7.5035 07/29/2016
Purchase of Common Stock 13,251 7.5200 08/04/2016
Purchase of Common Stock 8,299 6.3949 08/05/2016
Purchase of Common Stock 13,840 6.3960 08/05/2016

VIEX SPECIAL OPPORTUNITIES FUND II, LP

Purchase of Common Stock 6,002 7.1874 07/8/2016
Purchase of Common Stock 5,558 7.5000 07/27/2016
Short Sale of February 2017 Put Option ($7.50 Strike Price) 9 (2) 1.3500 07/27/2016
Purchase of Common Stock 24,501 7.5035 07/29/2016
Purchase of Common Stock 76,749 7.5200 08/04/2016
Purchase of Common Stock 48,067 6.3949 08/05/2016
Purchase of Common Stock 80,160 6.3960 08/05/2016

EFPlaceholder 1 Represents American-style put options sold short in the over-the-counter market. These put options expire on November 18, 2016.

2 Represents American-style put options sold short in the over-the-counter market. These put options expire on February 17, 2017.

EFPlaceholder